PRINCIPAL INVESTIGATOR TEAM 

MAIN PRINCIPAL INVESTIGATOR:
Rodrigo Jover

CO-PRINCIPAL INVESTIGATOR:
Michael Bretthauer

EPOS-III STUDY PI:
​Evelien Dekker 

​PARTICIPANTS:

• Geir Hoff
• Mette Kalager
• Magnus Løberg
• Siv Furholm
• Lars Aabakken
• Øyvind Holme
• Kjetil Kjeldstad Garborg
• Michal Filip Kaminski
• Hans-Olov Adami, Stockholm

---

Cooperation

The study is carried out by the Clinical Effectiveness research group and several outstanding research institutions in Europe and the United States:​

• Harvard T.H Chan School of Public Health, Boston
• Karolinska Instituttet, Stockholm
• Erasmus Medical Centre, Rotterdam,
• Marie Curie Sklodowska, Warsawa
• Sloan Kettering Memorial, New York City
• Uppsala Universitetssykehus, Uppsala
• Universitetssykehuset i Alicante, Spania
• Universitetssykehuset i Hamburg-Eppendorf
• Universitetet i Edinburgh,The Roslin Institute
• Deutsches Krebsforschungszentrum, Division of Preventive Oncology , Germany,
• Epidemiologia dei Tumori II. AOU S Giovanni Battista - CPO Piemonte. Torino, Italy.

​European EPoS Centres